Cathérine Reenaers
Centre Hospitalier Universitaire de Liège(BE)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Autoimmune and Inflammatory Disorders, Eosinophilic Esophagitis, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- → ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment(2024)263 cited
- → Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease(2010)187 cited
- → ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment(2024)119 cited
- → Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohnʼs disease with normal C-reactive protein serum level(2007)117 cited
- → Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients(2012)111 cited
- → Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring(2013)109 cited
- → Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission(2017)91 cited
- → The efficacy of shortening the dosing interval to once every six weeks in Crohn’s patients losing response to maintenance dose of infliximab(2010)90 cited
- → Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations: Table 1.(2015)85 cited
- → Does co‐treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?(2012)85 cited